Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-06 2:08 pm Purchase |
2025-02-28 | 13G | Merck & Co., Inc. MRK |
The Vanguard Group | 253,257,639 10.020% |
8,490,605 (+3.47%) |
Filing History |
| 2025-02-03 4:15 pm Purchase |
2025-01-31 | 13G | Evaxion Biotech A/S EVAX |
Merck & Co. Inc. MRK |
63,004,142 19.960% |
61,460,024 (+3980.27%) |
Filing History |
| 2024-12-23 07:32 am Purchase |
2024-12-19 | 13G | Personalis, Inc. PSNL |
Merck & Co. Inc. MRK |
14,044,943 16.500% |
14,044,943 (New Position) |
Filing History |
| 2024-11-06 4:09 pm Purchase |
2024-09-30 | 13G | Evaxion Biotech A/S EVAX |
Merck & Co. Inc. MRK |
1,544,118 12.900% |
625,000 (+68.00%) |
Filing History |
| 2024-02-13 4:55 pm Purchase |
2023-12-29 | 13G | Merck & Co., Inc. MRK |
The Vanguard Group | 244,767,034 9.660% |
17,561,056 (+7.73%) |
Filing History |
| 2024-01-26 11:49 am Sale |
2023-12-31 | 13G | Merck & Co., Inc. MRK |
BLACKROCK INC BLK |
201,836,434 8.000% |
-13,174,951 (-6.13%) |
Filing History |
| 2024-01-23 3:29 pm Purchase |
2023-12-21 | 13G | Evaxion Biotech A/S EVAX |
Merck & Co. Inc. MRK |
919,118 11.400% |
919,118 (New Position) |
Filing History |
| 2023-02-09 10:54 am Purchase |
2022-12-30 | 13G | Merck & Co., Inc. MRK |
The Vanguard Group | 227,205,978 8.960% |
16,003,447 (+7.58%) |
Filing History |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Merck & Co., Inc. MRK |
BLACKROCK INC BLK |
215,011,385 8.500% |
16,787,121 (+8.47%) |
Filing History |
| 2022-02-09 3:15 pm Sale |
2021-12-31 | 13G | Merck & Co., Inc. MRK |
The Vanguard Group | 211,202,531 8.360% |
-7,211,824 (-3.30%) |
Filing History |
| 2022-02-02 5:21 pm Purchase |
2021-12-31 | 13G | 4D pharma plc LBPS |
Merck & Co. Inc. MRK |
12,145,523 6.600% |
12,145,523 (New Position) |
Filing History |
| 2022-01-31 5:59 pm Sale |
2021-12-31 | 13G | Merck & Co., Inc. MRK |
BLACKROCK INC BLK |
198,224,264 7.800% |
-7,407,803 (-3.60%) |
Filing History |
| 2021-03-04 06:06 am Purchase |
2021-02-24 | 13D | PANDION THERAPEUTICS INC PAND |
Merck & Co. Inc. MRK |
11,776,706 39.990% |
11,776,706 (New Position) |
Filing History |
| 2021-02-10 10:02 am Sale |
2020-12-31 | 13G | Merck & Co., Inc. MRK |
The Vanguard Group | 218,414,355 8.240% |
-2,234,010 (-1.01%) |
Filing History |
| 2021-02-05 08:03 am Purchase |
2020-12-31 | 13G | Merck & Co., Inc. MRK |
BLACKROCK INC BLK |
205,632,067 7.800% |
5,691,247 (+2.85%) |
Filing History |
| 2021-01-04 2:28 pm Purchase |
2020-12-22 | 13G | Yumanity Therapeutics, Inc. YMTX |
Merck & Co. Inc. MRK |
75,286 5.200% |
75,286 (New Position) |
Filing History |